Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
GBIO | Generation Bio Co. | Director | $584K | +$125K | +27.2% | Jun 6, 2024 |
SYRE | Spyre Therapeutics, Inc. | President & CEO, Director | $580K | Mar 16, 2022 | ||
KLDO | Kaleido Biosciences, Inc. | Director | Jun 30, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|